XML 12 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2016
Mar. 31, 2016
ASSETS    
Cash and cash equivalents $ 6,509,589 $ 9,270,010
Accounts receivable, net of allowance for doubtful accounts of $769,000 and $601,000 at June 30, 2016 and March 31, 2016, respectively 3,999,532 3,392,941
Other receivables 315,233 581,213
Due from affiliates 20,052 20,505
Prepaid expenses and other current assets 509,010 293,828
Total current assets 11,353,416 13,558,497
Deferred financing costs 0 37,926
Property and equipment, net 1,341,984 1,247,973
Restricted cash 530,000 530,000
Intangible assets, net 2,258,054 2,353,212
Goodwill 1,622,483 1,622,483
Other assets 213,680 216,442
TOTAL ASSETS 17,319,617 19,566,533
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY    
Accounts payable and accrued liabilities 4,254,856 4,572,307
Medical liabilities 2,512,041 2,670,709
Note and line of credit 176,264 188,764
Total current liabilities 6,943,161 7,431,780
Warrant liability 1,988,889 2,811,111
Deferred rent liability 762,461 728,877
Deferred tax liability 43,479 43,479
Total liabilities 9,737,990 11,015,247
COMMITMENTS AND CONTINGENCIES
Series A Preferred stock, par value $0.001; 5,000,000 shares authorized (inclusive of Series B); 1,111,111 issued and outstanding Liquidation preference of $9,999,999 7,077,778 7,077,778
STOCKHOLDERS' EQUITY    
Common Stock, par value $0.001; 100,000,000 shares authorized, 5,998,518 and 5,876,852 shares issued and outstanding as of June 30, 2016 and March 31, 2016, respectively 5,998 5,876
Additional paid-in-capital 23,904,114 23,524,517
Accumulated deficit (29,999,822) (28,684,565)
Stockholders' deficit attributable to Apollo Medical Holdings, Inc. (2,204,965) (1,269,427)
Non-controlling interest 2,708,814 2,742,935
Total stockholders' equity 503,849 1,473,508
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 17,319,617 19,566,533
Series B Preferred Stock [Member]    
STOCKHOLDERS' EQUITY    
Series B Preferred stock, par value $0.001; 5,000,000 shares authorized (inclusive of Series A); 555,555 issued and outstanding Liquidation preference of $4,999,995 $ 3,884,745 $ 3,884,745